| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lower Urinary Tract Symptoms | 26 | 2025 | 76 | 6.490 |
Why?
|
| Chronic Pain | 17 | 2025 | 171 | 3.040 |
Why?
|
| Quality of Life | 21 | 2025 | 1744 | 2.600 |
Why?
|
| Depression | 21 | 2024 | 526 | 2.550 |
Why?
|
| Pelvic Pain | 14 | 2025 | 86 | 2.300 |
Why?
|
| Surveys and Questionnaires | 42 | 2025 | 2729 | 2.130 |
Why?
|
| Dermatitis, Atopic | 5 | 2025 | 62 | 2.080 |
Why?
|
| Cystitis, Interstitial | 9 | 2025 | 54 | 2.060 |
Why?
|
| Memory, Episodic | 10 | 2018 | 60 | 1.970 |
Why?
|
| Military Personnel | 4 | 2020 | 94 | 1.880 |
Why?
|
| Stress, Psychological | 10 | 2019 | 329 | 1.540 |
Why?
|
| Prostatic Hyperplasia | 2 | 2024 | 91 | 1.540 |
Why?
|
| Psychometrics | 18 | 2022 | 335 | 1.450 |
Why?
|
| Patient Reported Outcome Measures | 8 | 2024 | 259 | 1.360 |
Why?
|
| Anxiety | 12 | 2024 | 324 | 1.210 |
Why?
|
| Prostatitis | 5 | 2023 | 13 | 1.180 |
Why?
|
| Health Literacy | 4 | 2023 | 73 | 1.160 |
Why?
|
| Adolescent | 46 | 2025 | 9504 | 1.150 |
Why?
|
| Urinary Incontinence | 6 | 2022 | 216 | 1.150 |
Why?
|
| Male | 97 | 2025 | 43925 | 1.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2018 | 120 | 1.030 |
Why?
|
| Humans | 133 | 2025 | 92337 | 1.030 |
Why?
|
| Female | 98 | 2025 | 47893 | 1.010 |
Why?
|
| Mobile Applications | 2 | 2024 | 76 | 1.000 |
Why?
|
| Adult | 63 | 2025 | 27532 | 0.980 |
Why?
|
| Mental Recall | 4 | 2018 | 166 | 0.960 |
Why?
|
| Unemployment | 1 | 2024 | 11 | 0.930 |
Why?
|
| Return to Work | 1 | 2024 | 14 | 0.930 |
Why?
|
| Eczema | 2 | 2021 | 8 | 0.920 |
Why?
|
| Depressive Disorder, Major | 6 | 2013 | 171 | 0.900 |
Why?
|
| Taste Threshold | 3 | 2013 | 4 | 0.900 |
Why?
|
| Pain Measurement | 8 | 2025 | 360 | 0.900 |
Why?
|
| Suicide | 2 | 2016 | 151 | 0.850 |
Why?
|
| Self Report | 7 | 2020 | 307 | 0.840 |
Why?
|
| Middle Aged | 56 | 2025 | 27030 | 0.830 |
Why?
|
| Decision Support Techniques | 1 | 2025 | 175 | 0.830 |
Why?
|
| Young Adult | 28 | 2025 | 6624 | 0.770 |
Why?
|
| Severity of Illness Index | 17 | 2025 | 1919 | 0.760 |
Why?
|
| Anxiety Disorders | 9 | 2022 | 156 | 0.750 |
Why?
|
| Affect | 4 | 2021 | 391 | 0.700 |
Why?
|
| Vaccination | 1 | 2023 | 285 | 0.700 |
Why?
|
| Symptom Assessment | 4 | 2019 | 69 | 0.700 |
Why?
|
| Violence | 2 | 2020 | 149 | 0.690 |
Why?
|
| Aged | 40 | 2025 | 19943 | 0.690 |
Why?
|
| Fear | 5 | 2023 | 82 | 0.680 |
Why?
|
| Psychology, Adolescent | 2 | 2011 | 29 | 0.670 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 74 | 0.660 |
Why?
|
| Hydrocortisone | 3 | 2013 | 304 | 0.650 |
Why?
|
| Neurotic Disorders | 6 | 2011 | 13 | 0.650 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 518 | 0.630 |
Why?
|
| Urinary Incontinence, Urge | 5 | 2025 | 50 | 0.620 |
Why?
|
| Taste Perception | 3 | 2013 | 4 | 0.620 |
Why?
|
| Prospective Studies | 18 | 2025 | 4468 | 0.620 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2015 | 130 | 0.590 |
Why?
|
| Self-Injurious Behavior | 2 | 2025 | 114 | 0.590 |
Why?
|
| Critical Illness | 1 | 2020 | 328 | 0.560 |
Why?
|
| Urinary Incontinence, Stress | 4 | 2023 | 198 | 0.560 |
Why?
|
| Urinary Bladder | 5 | 2022 | 250 | 0.540 |
Why?
|
| Cross-Sectional Studies | 13 | 2024 | 1774 | 0.510 |
Why?
|
| Attitude | 3 | 2014 | 129 | 0.510 |
Why?
|
| Factor Analysis, Statistical | 9 | 2019 | 117 | 0.480 |
Why?
|
| Longitudinal Studies | 14 | 2025 | 1119 | 0.470 |
Why?
|
| Self Concept | 5 | 2018 | 135 | 0.470 |
Why?
|
| Combat Disorders | 1 | 2015 | 4 | 0.470 |
Why?
|
| Reproducibility of Results | 15 | 2022 | 2794 | 0.470 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 137 | 0.470 |
Why?
|
| Hearing Loss | 5 | 2019 | 63 | 0.470 |
Why?
|
| Child | 16 | 2025 | 7334 | 0.470 |
Why?
|
| Status Epilepticus | 2 | 2005 | 41 | 0.460 |
Why?
|
| Sleep Wake Disorders | 3 | 2022 | 121 | 0.460 |
Why?
|
| Adolescent Behavior | 3 | 2011 | 110 | 0.460 |
Why?
|
| Personality | 4 | 2019 | 139 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 276 | 0.450 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 95 | 0.450 |
Why?
|
| Emotions | 5 | 2018 | 365 | 0.450 |
Why?
|
| Candy | 1 | 2014 | 3 | 0.450 |
Why?
|
| Cacao | 1 | 2014 | 3 | 0.450 |
Why?
|
| Craving | 1 | 2014 | 23 | 0.430 |
Why?
|
| Phenotype | 6 | 2025 | 2498 | 0.430 |
Why?
|
| Parenting | 1 | 2014 | 74 | 0.430 |
Why?
|
| Social Support | 2 | 2015 | 222 | 0.420 |
Why?
|
| Resilience, Psychological | 2 | 2013 | 32 | 0.420 |
Why?
|
| Propylthiouracil | 1 | 2013 | 27 | 0.420 |
Why?
|
| Neuropsychological Tests | 3 | 2013 | 523 | 0.410 |
Why?
|
| Depressive Disorder | 5 | 2014 | 224 | 0.410 |
Why?
|
| Psychological Tests | 3 | 2017 | 91 | 0.410 |
Why?
|
| Urinary Tract | 2 | 2023 | 35 | 0.400 |
Why?
|
| Child, Preschool | 10 | 2025 | 3818 | 0.400 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 67 | 0.400 |
Why?
|
| United States | 19 | 2024 | 7348 | 0.390 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 1 | 0.380 |
Why?
|
| Saliva | 3 | 2013 | 126 | 0.380 |
Why?
|
| Brain | 6 | 2020 | 2352 | 0.380 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 887 | 0.380 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2025 | 73 | 0.370 |
Why?
|
| Personality Development | 1 | 2011 | 23 | 0.370 |
Why?
|
| Self-Management | 2 | 2023 | 43 | 0.370 |
Why?
|
| Skin Diseases | 2 | 2024 | 175 | 0.360 |
Why?
|
| Time Factors | 8 | 2021 | 5430 | 0.360 |
Why?
|
| Crime Victims | 1 | 2011 | 42 | 0.360 |
Why?
|
| Uracil | 1 | 2011 | 55 | 0.360 |
Why?
|
| Predictive Value of Tests | 4 | 2017 | 1763 | 0.340 |
Why?
|
| Cues | 4 | 2014 | 177 | 0.320 |
Why?
|
| Wakefulness | 1 | 2010 | 136 | 0.320 |
Why?
|
| Criminals | 2 | 2020 | 33 | 0.310 |
Why?
|
| Models, Psychological | 6 | 2018 | 161 | 0.310 |
Why?
|
| Prevalence | 6 | 2025 | 1294 | 0.310 |
Why?
|
| Cohort Studies | 11 | 2025 | 2978 | 0.300 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2019 | 12 | 0.300 |
Why?
|
| Cluster Analysis | 5 | 2022 | 376 | 0.300 |
Why?
|
| Thinking | 3 | 2014 | 35 | 0.300 |
Why?
|
| Health Status Indicators | 2 | 2019 | 103 | 0.300 |
Why?
|
| Memory Disorders | 2 | 2023 | 70 | 0.290 |
Why?
|
| Ear Diseases | 2 | 2019 | 21 | 0.290 |
Why?
|
| Sex Factors | 8 | 2025 | 1095 | 0.290 |
Why?
|
| Pain | 3 | 2022 | 406 | 0.290 |
Why?
|
| Affective Symptoms | 3 | 2015 | 52 | 0.290 |
Why?
|
| Biomedical Research | 3 | 2018 | 404 | 0.280 |
Why?
|
| Parents | 2 | 2025 | 296 | 0.280 |
Why?
|
| Nocturia | 4 | 2025 | 22 | 0.270 |
Why?
|
| Risk Factors | 12 | 2019 | 5704 | 0.270 |
Why?
|
| Prisoners | 2 | 2020 | 46 | 0.270 |
Why?
|
| Hearing Aids | 4 | 2019 | 8 | 0.260 |
Why?
|
| Eflornithine | 5 | 2007 | 16 | 0.260 |
Why?
|
| Pelvic Organ Prolapse | 2 | 2019 | 165 | 0.260 |
Why?
|
| Nitrogen Oxides | 1 | 2005 | 15 | 0.250 |
Why?
|
| Cognition | 5 | 2020 | 603 | 0.250 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 60 | 0.250 |
Why?
|
| Benzenesulfonates | 1 | 2005 | 50 | 0.240 |
Why?
|
| Age Factors | 7 | 2025 | 1905 | 0.240 |
Why?
|
| Back Pain | 2 | 2016 | 65 | 0.240 |
Why?
|
| Self-Assessment | 1 | 2025 | 48 | 0.240 |
Why?
|
| Sleep | 4 | 2022 | 461 | 0.240 |
Why?
|
| Mental Health | 2 | 2024 | 184 | 0.230 |
Why?
|
| Amino Acids, Cyclic | 1 | 2004 | 2 | 0.230 |
Why?
|
| Cycloserine | 1 | 2004 | 5 | 0.230 |
Why?
|
| Antimetabolites | 1 | 2004 | 24 | 0.230 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 11 | 0.230 |
Why?
|
| Kinesthesis | 2 | 2015 | 15 | 0.230 |
Why?
|
| Focus Groups | 1 | 2025 | 186 | 0.220 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 89 | 0.220 |
Why?
|
| Ureteral Obstruction | 1 | 2024 | 69 | 0.220 |
Why?
|
| Behavior Therapy | 1 | 2024 | 93 | 0.220 |
Why?
|
| Social Participation | 1 | 2023 | 15 | 0.220 |
Why?
|
| Circadian Rhythm | 3 | 2013 | 309 | 0.220 |
Why?
|
| Social Stigma | 1 | 2024 | 76 | 0.210 |
Why?
|
| Mental Disorders | 2 | 2018 | 424 | 0.210 |
Why?
|
| Psychological Trauma | 1 | 2023 | 8 | 0.210 |
Why?
|
| Chronic Disease | 6 | 2024 | 963 | 0.210 |
Why?
|
| Boston | 1 | 2023 | 37 | 0.210 |
Why?
|
| Caregivers | 1 | 2025 | 177 | 0.200 |
Why?
|
| Pain Threshold | 1 | 2023 | 61 | 0.200 |
Why?
|
| Urination | 2 | 2020 | 40 | 0.200 |
Why?
|
| Internet | 1 | 2025 | 331 | 0.200 |
Why?
|
| Logistic Models | 5 | 2025 | 1239 | 0.200 |
Why?
|
| Longevity | 2 | 2015 | 58 | 0.200 |
Why?
|
| Urodynamics | 2 | 2020 | 125 | 0.200 |
Why?
|
| Sexual Behavior | 1 | 2025 | 320 | 0.200 |
Why?
|
| Sewage | 1 | 2002 | 3 | 0.190 |
Why?
|
| Waste Disposal, Fluid | 1 | 2002 | 3 | 0.190 |
Why?
|
| Environmental Pollution | 1 | 2002 | 13 | 0.190 |
Why?
|
| Polyamines | 3 | 2007 | 38 | 0.190 |
Why?
|
| Low Back Pain | 1 | 2022 | 51 | 0.190 |
Why?
|
| Fracture Healing | 1 | 2021 | 38 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 291 | 0.190 |
Why?
|
| Personality Inventory | 4 | 2010 | 109 | 0.180 |
Why?
|
| Chicago | 3 | 2023 | 1466 | 0.180 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2022 | 91 | 0.180 |
Why?
|
| Reflex, Startle | 2 | 2014 | 32 | 0.180 |
Why?
|
| Hip Fractures | 1 | 2021 | 50 | 0.180 |
Why?
|
| Pelvic Floor Disorders | 2 | 2019 | 56 | 0.180 |
Why?
|
| Self Care | 2 | 2023 | 169 | 0.180 |
Why?
|
| Food Preferences | 2 | 2011 | 27 | 0.180 |
Why?
|
| Afghan Campaign 2001- | 1 | 2020 | 5 | 0.180 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2020 | 5 | 0.180 |
Why?
|
| Absorptiometry, Photon | 2 | 2019 | 106 | 0.180 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2020 | 17 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 3509 | 0.180 |
Why?
|
| Schools | 1 | 2021 | 79 | 0.170 |
Why?
|
| Personality Assessment | 2 | 2011 | 97 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2022 | 104 | 0.170 |
Why?
|
| Patient Participation | 2 | 2019 | 228 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2013 | 498 | 0.170 |
Why?
|
| Qualitative Research | 2 | 2023 | 325 | 0.170 |
Why?
|
| Educational Status | 1 | 2020 | 197 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 270 | 0.170 |
Why?
|
| Video Games | 1 | 2019 | 10 | 0.160 |
Why?
|
| Bone Density | 2 | 2019 | 226 | 0.160 |
Why?
|
| General Practitioners | 1 | 2019 | 11 | 0.160 |
Why?
|
| Pandemics | 2 | 2023 | 812 | 0.160 |
Why?
|
| Genotype | 4 | 2013 | 1863 | 0.160 |
Why?
|
| Neuroimaging | 1 | 2020 | 127 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 1235 | 0.160 |
Why?
|
| Health Promotion | 1 | 2021 | 168 | 0.160 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 40 | 0.160 |
Why?
|
| Scoliosis | 1 | 2019 | 33 | 0.160 |
Why?
|
| Intracellular Space | 1 | 2019 | 38 | 0.160 |
Why?
|
| Decision Making | 1 | 2025 | 680 | 0.160 |
Why?
|
| Health Behavior | 2 | 2023 | 185 | 0.160 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2019 | 41 | 0.160 |
Why?
|
| Hearing Tests | 1 | 2018 | 11 | 0.150 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 211 | 0.150 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 107 | 0.150 |
Why?
|
| Contraindications | 1 | 2018 | 70 | 0.150 |
Why?
|
| Rumination, Cognitive | 1 | 2018 | 2 | 0.150 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 342 | 0.150 |
Why?
|
| Teaching | 1 | 2019 | 146 | 0.150 |
Why?
|
| Interpersonal Relations | 2 | 2011 | 179 | 0.150 |
Why?
|
| Syndrome | 4 | 2022 | 449 | 0.150 |
Why?
|
| Disease Progression | 5 | 2015 | 1503 | 0.150 |
Why?
|
| Mice, Inbred DBA | 4 | 2015 | 148 | 0.150 |
Why?
|
| Placebos | 1 | 2018 | 211 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2020 | 800 | 0.150 |
Why?
|
| Fecal Incontinence | 1 | 2018 | 59 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 2009 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 280 | 0.140 |
Why?
|
| Connectome | 1 | 2018 | 81 | 0.140 |
Why?
|
| Femur Neck | 2 | 2019 | 44 | 0.140 |
Why?
|
| Catastrophization | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 166 | 0.140 |
Why?
|
| Chromosomes, Mammalian | 2 | 2015 | 37 | 0.140 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 451 | 0.140 |
Why?
|
| Association Learning | 2 | 2014 | 37 | 0.130 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 107 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 446 | 0.130 |
Why?
|
| Motivation | 1 | 2019 | 310 | 0.130 |
Why?
|
| Quantitative Trait Loci | 3 | 2010 | 623 | 0.130 |
Why?
|
| Homeostasis | 1 | 2019 | 450 | 0.130 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 169 | 0.130 |
Why?
|
| Mood Disorders | 2 | 2014 | 83 | 0.130 |
Why?
|
| Nerve Net | 2 | 2019 | 396 | 0.130 |
Why?
|
| Rats | 5 | 2021 | 4067 | 0.130 |
Why?
|
| Amygdala | 1 | 2016 | 87 | 0.120 |
Why?
|
| Aged, 80 and over | 6 | 2015 | 6916 | 0.120 |
Why?
|
| Pilocarpine | 2 | 2005 | 7 | 0.120 |
Why?
|
| Touch | 2 | 2015 | 105 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 158 | 0.120 |
Why?
|
| Phobic Disorders | 2 | 2014 | 13 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 159 | 0.120 |
Why?
|
| Firearms | 1 | 2016 | 68 | 0.120 |
Why?
|
| White Matter | 1 | 2016 | 86 | 0.120 |
Why?
|
| Lithium | 2 | 2005 | 63 | 0.120 |
Why?
|
| HIV Infections | 1 | 2024 | 895 | 0.120 |
Why?
|
| Executive Function | 2 | 2018 | 99 | 0.120 |
Why?
|
| Aggression | 1 | 2018 | 324 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 1045 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2015 | 60 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 141 | 0.110 |
Why?
|
| Patient Care Team | 2 | 2015 | 295 | 0.110 |
Why?
|
| Animals | 18 | 2021 | 28003 | 0.110 |
Why?
|
| Health Status | 3 | 2024 | 376 | 0.110 |
Why?
|
| Sucrose | 2 | 2013 | 65 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 115 | 0.110 |
Why?
|
| Guilt | 1 | 2014 | 11 | 0.110 |
Why?
|
| Behavioral Symptoms | 1 | 2014 | 15 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 814 | 0.110 |
Why?
|
| Interview, Psychological | 2 | 2011 | 69 | 0.110 |
Why?
|
| Touch Perception | 1 | 2015 | 68 | 0.110 |
Why?
|
| Awareness | 1 | 2014 | 89 | 0.110 |
Why?
|
| Dyspareunia | 1 | 2013 | 22 | 0.100 |
Why?
|
| Noise | 1 | 2013 | 26 | 0.100 |
Why?
|
| Taste | 1 | 2013 | 29 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 46 | 0.100 |
Why?
|
| Tongue | 1 | 2013 | 56 | 0.100 |
Why?
|
| Hippocampus | 1 | 2016 | 435 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 542 | 0.100 |
Why?
|
| Arteritis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Dysmenorrhea | 1 | 2013 | 56 | 0.100 |
Why?
|
| Calcaneus | 1 | 2012 | 40 | 0.100 |
Why?
|
| Hip Joint | 1 | 2012 | 54 | 0.100 |
Why?
|
| Auditory Perception | 1 | 2013 | 98 | 0.100 |
Why?
|
| Comorbidity | 4 | 2023 | 987 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2012 | 86 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2003 | 127 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 83 | 0.090 |
Why?
|
| Pruritus | 2 | 2021 | 29 | 0.090 |
Why?
|
| Heart-Assist Devices | 2 | 2012 | 866 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 1212 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 335 | 0.090 |
Why?
|
| Multimedia | 1 | 2011 | 9 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2012 | 124 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 3360 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2011 | 50 | 0.090 |
Why?
|
| Smoking | 1 | 2014 | 640 | 0.090 |
Why?
|
| Sex Characteristics | 4 | 2019 | 331 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2005 | 771 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 800 | 0.080 |
Why?
|
| Language | 2 | 2022 | 159 | 0.080 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 2010 | 2 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 738 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2019 | 2369 | 0.080 |
Why?
|
| Rest | 2 | 2020 | 51 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2011 | 187 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2023 | 351 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2011 | 235 | 0.080 |
Why?
|
| Personality Tests | 1 | 2008 | 21 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2012 | 909 | 0.080 |
Why?
|
| Health | 1 | 2008 | 29 | 0.070 |
Why?
|
| Corneal Neovascularization | 1 | 2008 | 1 | 0.070 |
Why?
|
| Culture | 1 | 2008 | 53 | 0.070 |
Why?
|
| Granulation Tissue | 1 | 2008 | 15 | 0.070 |
Why?
|
| Mice | 10 | 2019 | 12110 | 0.070 |
Why?
|
| Lung Neoplasms | 4 | 2007 | 2394 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1902 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2007 | 1071 | 0.070 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2018 | 3 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 306 | 0.070 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2007 | 57 | 0.070 |
Why?
|
| Naltrexone | 1 | 2008 | 139 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 810 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 578 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 3775 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 165 | 0.060 |
Why?
|
| Heart Rate | 1 | 2008 | 502 | 0.060 |
Why?
|
| Cyclic N-Oxides | 1 | 2005 | 33 | 0.060 |
Why?
|
| Cottontail rabbit papillomavirus | 1 | 2005 | 1 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2018 | 131 | 0.060 |
Why?
|
| Materials Testing | 1 | 2006 | 94 | 0.060 |
Why?
|
| Y Chromosome | 1 | 2005 | 29 | 0.060 |
Why?
|
| Mouth Diseases | 1 | 2005 | 16 | 0.060 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 2 | 2003 | 4 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 136 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2019 | 325 | 0.060 |
Why?
|
| Warfare | 1 | 2005 | 11 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 8740 | 0.060 |
Why?
|
| Family Therapy | 1 | 2005 | 16 | 0.060 |
Why?
|
| Psychotherapy, Group | 1 | 2005 | 35 | 0.060 |
Why?
|
| Muscarinic Agonists | 1 | 2004 | 23 | 0.060 |
Why?
|
| Parasympathetic Nervous System | 1 | 2004 | 36 | 0.060 |
Why?
|
| Stereotyping | 1 | 2024 | 16 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 197 | 0.060 |
Why?
|
| France | 1 | 2024 | 51 | 0.060 |
Why?
|
| Schizophrenic Psychology | 1 | 2005 | 139 | 0.060 |
Why?
|
| Mass Screening | 2 | 2019 | 675 | 0.060 |
Why?
|
| Coinfection | 1 | 2024 | 63 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 219 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2019 | 580 | 0.050 |
Why?
|
| Canada | 1 | 2024 | 205 | 0.050 |
Why?
|
| Ecological Momentary Assessment | 1 | 2024 | 33 | 0.050 |
Why?
|
| Ureter | 1 | 2024 | 96 | 0.050 |
Why?
|
| Lumbar Vertebrae | 2 | 2019 | 288 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 197 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 595 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2025 | 9703 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 505 | 0.050 |
Why?
|
| ROC Curve | 2 | 2017 | 785 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 652 | 0.050 |
Why?
|
| Workplace | 1 | 2022 | 30 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 172 | 0.050 |
Why?
|
| Biogenic Polyamines | 1 | 2002 | 2 | 0.050 |
Why?
|
| Enkephalin, Methionine | 1 | 2002 | 5 | 0.050 |
Why?
|
| Naproxen | 1 | 2022 | 15 | 0.050 |
Why?
|
| Placebo Effect | 1 | 2022 | 34 | 0.050 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 2002 | 12 | 0.050 |
Why?
|
| Motor Activity | 1 | 2004 | 330 | 0.050 |
Why?
|
| Weaning | 1 | 2002 | 25 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2021 | 21 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 3872 | 0.050 |
Why?
|
| Pregnancy, Animal | 1 | 2002 | 58 | 0.050 |
Why?
|
| Pelvis | 1 | 2022 | 96 | 0.050 |
Why?
|
| Postural Balance | 1 | 2021 | 50 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2023 | 147 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2019 | 1142 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 370 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2005 | 2448 | 0.050 |
Why?
|
| Vibration | 1 | 2021 | 51 | 0.050 |
Why?
|
| Electronics | 1 | 2021 | 18 | 0.050 |
Why?
|
| Neoplasm Transplantation | 3 | 2007 | 398 | 0.050 |
Why?
|
| Conservation of Natural Resources | 1 | 2002 | 88 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2005 | 501 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2010 | 1076 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 500 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 51 | 0.040 |
Why?
|
| Criminal Behavior | 1 | 2020 | 3 | 0.040 |
Why?
|
| Algorithms | 2 | 2019 | 1956 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 402 | 0.040 |
Why?
|
| Narration | 1 | 2020 | 17 | 0.040 |
Why?
|
| Temperature | 1 | 2002 | 404 | 0.040 |
Why?
|
| Information Systems | 1 | 2020 | 30 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2002 | 524 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 246 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 168 | 0.040 |
Why?
|
| Water | 1 | 2002 | 292 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2004 | 362 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 37 | 0.040 |
Why?
|
| Actigraphy | 1 | 2020 | 60 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 224 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 242 | 0.040 |
Why?
|
| Kyphosis | 1 | 2019 | 19 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 3053 | 0.040 |
Why?
|
| Radius | 1 | 2019 | 31 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 98 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 2019 | 29 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2019 | 78 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2019 | 54 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 123 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 105 | 0.040 |
Why?
|
| Jejunum | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cattle | 2 | 2012 | 380 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 107 | 0.040 |
Why?
|
| Poland | 1 | 2018 | 18 | 0.040 |
Why?
|
| Actomyosin | 1 | 2019 | 47 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 69 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 142 | 0.040 |
Why?
|
| Government Regulation | 1 | 2018 | 50 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 547 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 1271 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2018 | 50 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 151 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 137 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2010 | 171 | 0.040 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2019 | 159 | 0.040 |
Why?
|
| Consensus | 1 | 2019 | 376 | 0.030 |
Why?
|
| Constipation | 1 | 2018 | 69 | 0.030 |
Why?
|
| Hypertension | 1 | 2023 | 763 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 108 | 0.030 |
Why?
|
| Mice, Nude | 3 | 2005 | 828 | 0.030 |
Why?
|
| Diarrhea | 1 | 2018 | 180 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 611 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 17 | 0.030 |
Why?
|
| Oxygen | 1 | 2002 | 763 | 0.030 |
Why?
|
| Ear Neoplasms | 1 | 2016 | 13 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 435 | 0.030 |
Why?
|
| Urology | 1 | 2018 | 125 | 0.030 |
Why?
|
| Functional Neuroimaging | 1 | 2016 | 31 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1398 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 760 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2010 | 220 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 2669 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 69 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 103 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 490 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2007 | 90 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 112 | 0.030 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2016 | 90 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1756 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 996 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 709 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2016 | 130 | 0.030 |
Why?
|
| Proprioception | 1 | 2015 | 32 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 3218 | 0.030 |
Why?
|
| Test Anxiety Scale | 1 | 2014 | 2 | 0.030 |
Why?
|
| Anthracenes | 1 | 2014 | 16 | 0.030 |
Why?
|
| Prodromal Symptoms | 1 | 2014 | 1 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 2014 | 65 | 0.030 |
Why?
|
| Laminin | 2 | 2006 | 93 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2006 | 206 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2006 | 126 | 0.030 |
Why?
|
| Germany, East | 1 | 2013 | 1 | 0.030 |
Why?
|
| Germany, West | 1 | 2013 | 3 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 207 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2015 | 623 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1661 | 0.030 |
Why?
|
| Acoustic Impedance Tests | 1 | 2013 | 3 | 0.030 |
Why?
|
| Quinine | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2013 | 64 | 0.030 |
Why?
|
| Politics | 1 | 2013 | 51 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2013 | 81 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2013 | 26 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 1025 | 0.030 |
Why?
|
| Collagen | 2 | 2006 | 303 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 2012 | 34 | 0.020 |
Why?
|
| Infarction | 1 | 2012 | 27 | 0.020 |
Why?
|
| beta-Lactams | 1 | 2012 | 14 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 611 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 225 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2014 | 204 | 0.020 |
Why?
|
| Los Angeles | 1 | 2011 | 29 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1141 | 0.020 |
Why?
|
| Life Change Events | 1 | 2011 | 48 | 0.020 |
Why?
|
| Eosinophils | 1 | 2012 | 197 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2005 | 569 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 955 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2014 | 265 | 0.020 |
Why?
|
| Word Association Tests | 1 | 2011 | 5 | 0.020 |
Why?
|
| Stroop Test | 1 | 2011 | 10 | 0.020 |
Why?
|
| Lung | 2 | 2012 | 1337 | 0.020 |
Why?
|
| Psychological Theory | 1 | 2011 | 23 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1079 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 600 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1052 | 0.020 |
Why?
|
| Dependent Personality Disorder | 1 | 2009 | 1 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 330 | 0.020 |
Why?
|
| Psychopathology | 1 | 2010 | 30 | 0.020 |
Why?
|
| Lod Score | 1 | 2010 | 153 | 0.020 |
Why?
|
| Breeding | 1 | 2010 | 41 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 708 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 427 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2007 | 1720 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 456 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2680 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 2009 | 117 | 0.020 |
Why?
|
| Galvanic Skin Response | 1 | 2008 | 12 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2008 | 47 | 0.020 |
Why?
|
| Achievement | 1 | 2008 | 29 | 0.020 |
Why?
|
| Blinking | 1 | 2008 | 17 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2008 | 45 | 0.020 |
Why?
|
| Pediatrics | 1 | 2013 | 368 | 0.020 |
Why?
|
| Fluorophotometry | 1 | 2008 | 3 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 298 | 0.020 |
Why?
|
| Ophthalmic Solutions | 1 | 2008 | 17 | 0.020 |
Why?
|
| Epithelium, Corneal | 1 | 2008 | 14 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 90 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2008 | 97 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2008 | 129 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 59 | 0.020 |
Why?
|
| Memory | 1 | 2010 | 223 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2008 | 287 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2008 | 371 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 660 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 902 | 0.020 |
Why?
|
| Putrescine | 1 | 2006 | 7 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 192 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1150 | 0.020 |
Why?
|
| Spermine | 1 | 2006 | 25 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1145 | 0.020 |
Why?
|
| Spermidine | 1 | 2006 | 13 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 66 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2008 | 245 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 126 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 122 | 0.020 |
Why?
|
| Polyurethanes | 1 | 2006 | 14 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2006 | 29 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2006 | 21 | 0.020 |
Why?
|
| Titanium | 1 | 2006 | 24 | 0.020 |
Why?
|
| Capsid | 1 | 2005 | 25 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 146 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 271 | 0.020 |
Why?
|
| Surface Properties | 1 | 2006 | 131 | 0.020 |
Why?
|
| Wound Healing | 1 | 2008 | 373 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2006 | 60 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 997 | 0.020 |
Why?
|
| Yugoslavia | 1 | 2005 | 1 | 0.010 |
Why?
|
| Amidines | 1 | 2005 | 2 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 474 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2005 | 54 | 0.010 |
Why?
|
| Indans | 1 | 2005 | 35 | 0.010 |
Why?
|
| Equipment Design | 1 | 2006 | 418 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 542 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 2368 | 0.010 |
Why?
|
| Rabbits | 1 | 2005 | 644 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2005 | 62 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 1108 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2008 | 855 | 0.010 |
Why?
|
| Cell Death | 1 | 2005 | 261 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 180 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 140 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 236 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 312 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 573 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 142 | 0.010 |
Why?
|
| Opioid Peptides | 1 | 2002 | 6 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 2002 | 10 | 0.010 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2002 | 7 | 0.010 |
Why?
|
| Litter Size | 1 | 2002 | 13 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2002 | 52 | 0.010 |
Why?
|
| Fetal Death | 1 | 2002 | 57 | 0.010 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2002 | 19 | 0.010 |
Why?
|
| Vimentin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 307 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1723 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 258 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2317 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 2002 | 46 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 370 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2002 | 60 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1807 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1733 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 375 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 1180 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2005 | 393 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2447 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1743 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1399 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2002 | 434 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 552 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1939 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 803 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 3110 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 1684 | 0.010 |
Why?
|